Market Pulse
Structured intelligence on corporate strategy, market moves, and industry signals.
Each entry is a briefing, not a headline: event summary, strategic context, and what to watch next.
A Company Pulse is our reading of what a company says in its own press release, with the questions we would want answered. It is not verified reporting and it is not an endorsement. Pulses are made from press releases we collect from several sources, including Wire. Nobody can pay for a Pulse.
Werner Enterprises will participate in Deutsche Bank’s Chicago Industrials Summit on August 11, 2026.
Read full analysis →
Arcus Biosciences reported a $91 million net loss for Q2 2026, with cash reserves decreasing to $775 million from $1.0 billion at the end of 2025.
Read full analysis →
Corpay reported Q2 2026 revenue growth of 21% to $1.34 billion, with adjusted net income per share up 36%.
Read full analysis →
Klaviyo to acquire Agency's team and technology, strengthening its AI capabilities in CRM.
Read full analysis →
$2.05 billion strategic capital partnership with Ishbia Family and Oaktree, including $1.65 billion in preferred equity and warrants.
Read full analysis →
Aetna updated its Glaucoma Surgery Policy to recognize OMNI and SION as medically necessary for mild-to-moderate open-angle glaucoma.
Read full analysis →
SoundHound AI reported Q2 revenue of $61.9M, up 45% YoY.
Read full analysis →
Manulife's Board of Directors declared a quarterly common share dividend of $0.485 per share.
Read full analysis →
Amtech Systems reported $22.4M in Q3 revenue, up 14.5% YoY, driven by AI semiconductor packaging demand.
Read full analysis →
Permian Resources declared a quarterly base cash dividend of $0.16 per share, annualized at $0.64.
Read full analysis →
Alvopetro reported Q2 2026 sales volumes of 3,067 boepd, up 26% YoY, with revenues of $19.2 million and funds flow from operations of $14.1 million.
Read full analysis →
FDA accepted the NDA for daraxonrasib in metastatic pancreatic cancer, following Phase 3 RASolute 302 results.
Read full analysis →
Aeva launches Optical Connectivity business, leveraging its photonics technology for AI data centers.
Read full analysis →
Q2 2026 revenue of $18.9M, up 57% YoY
Read full analysis →
Nima Ghamsari, Co-Founder and Head of Blend, will participate in a fireside chat on August 12, 2026.
Read full analysis →
Q2 net income fell 17.2% YoY to $21.9M, with core income dropping 38.5% to $16.5M.
Read full analysis →
Total end-of-period subscribers at 2.5 million, with Clinical subscribers up 55.7% year-over-year.
Read full analysis →
Howard Hughes closed the $2.1 billion acquisition of Vantage Group Holdings on June 4, 2026.
Read full analysis →
Net income attributable to LMHC rose 42.8% YoY to $2.634 billion for Q2 2026, with a consolidated combined ratio of 87.3% YTD.
Read full analysis →
MannKind achieved three FDA approvals in Q2 2026: pediatric Afrezza, Furoscix ReadyFlow autoinjector, and positive Phase 1b data for nintedanib DPI.
Read full analysis →
